ATE303814T1 - Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos - Google Patents

Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos

Info

Publication number
ATE303814T1
ATE303814T1 AT00945665T AT00945665T ATE303814T1 AT E303814 T1 ATE303814 T1 AT E303814T1 AT 00945665 T AT00945665 T AT 00945665T AT 00945665 T AT00945665 T AT 00945665T AT E303814 T1 ATE303814 T1 AT E303814T1
Authority
AT
Austria
Prior art keywords
breast cancer
estrogen
composition
risk
steoridish
Prior art date
Application number
AT00945665T
Other languages
English (en)
Inventor
Nils Bruenner
Mogens Spang-Thomsen
Original Assignee
Uinv Kobenhavns
Rigshospitalet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8100258&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE303814(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Uinv Kobenhavns, Rigshospitalet filed Critical Uinv Kobenhavns
Application granted granted Critical
Publication of ATE303814T1 publication Critical patent/ATE303814T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00945665T 1999-07-15 2000-07-17 Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos ATE303814T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901034 1999-07-15
PCT/DK2000/000406 WO2001005415A2 (en) 1999-07-15 2000-07-17 Composition having steroidal estrogen effect without increasing the risk of breast cancer

Publications (1)

Publication Number Publication Date
ATE303814T1 true ATE303814T1 (de) 2005-09-15

Family

ID=8100258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945665T ATE303814T1 (de) 1999-07-15 2000-07-17 Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos

Country Status (7)

Country Link
EP (1) EP1200107B1 (de)
AT (1) ATE303814T1 (de)
AU (1) AU771581B2 (de)
DE (1) DE60022517T2 (de)
DK (1) DK1200107T3 (de)
ES (1) ES2249278T3 (de)
WO (1) WO2001005415A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2300783T3 (es) * 2003-07-01 2008-06-16 Max Zeller Sohne Ag Procedimiento de extraccion vegetal y extracto.
BRPI0711525A2 (pt) 2006-06-02 2011-11-01 Pear Tree Women S Health Care composição farmacêutica e método para tratar sintomas de vaginite atrófica
KR20150016373A (ko) 2012-07-03 2015-02-11 막스 젤러 죈네 악티엔게젤샤프트 시미시푸가 추출물의 신규한 약학적 용도
RU2680603C1 (ru) * 2018-11-08 2019-02-25 Ильясов Шамиль Сионович Применение 3-о-сульфамата-16,16-диметил-d-гомоэквиленина для лечения онкологических заболеваний
IT201900000343A1 (it) 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa

Also Published As

Publication number Publication date
ES2249278T3 (es) 2006-04-01
EP1200107B1 (de) 2005-09-07
AU771581B2 (en) 2004-03-25
WO2001005415A3 (en) 2001-05-25
EP1200107A2 (de) 2002-05-02
DK1200107T3 (da) 2006-01-16
DE60022517T2 (de) 2006-08-03
AU5966900A (en) 2001-02-05
WO2001005415A2 (en) 2001-01-25
DE60022517D1 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
Luo et al. Lycium barbarum polysaccharides induce apoptosis in human prostate cancer cells and inhibits prostate cancer growth in a xenograft mouse model of human prostate cancer
Hsieh et al. Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines
Boisvert et al. Hair growth-promoting effect of Geranium sibiricum extract in human dermal papilla cells and C57BL/6 mice
Nassar et al. Chemical constituents and anti‐ulcerogenic potential of the scales of Cynara scolymus (artichoke) heads
Zugic et al. Evaluation of anticancer and antioxidant activity of a commercially available CO2 supercritical extract of old man’s beard (Usnea barbata)
DE60018881D1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
Lee et al. Sanguinarine induces apoptosis of human oral squamous cell carcinoma KB cells via inactivation of the PI3K/Akt signaling pathway
Jeremic et al. The mechanisms of in vitro cytotoxicity of mountain tea, Sideritis scardica, against the C6 glioma cell line
Strzemski et al. In vitro antiproliferative activity of extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka
Wang et al. Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway
Park et al. Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells
Shen et al. A polysaccharide from Glycyrrhiza inflata Licorice inhibits proliferation of human oral cancer cells by inducing apoptosis via mitochondrial pathway
Kim et al. Amentoflavone, active compound of Selaginella tamariscina, inhibits in vitro and in vivo TGF-β-induced metastasis of human cancer cells
Koriem et al. Protective effect of Cupressus sempervirens extract against indomethacin-induced gastric ulcer in rats
Lee et al. Anticancer effects on human pancreatic cancer cells of triterpenoids, polysaccharides and 1, 3-β-D-glucan derived from the fruiting body of Antrodia camphorata
Martino et al. Polyphenol‐rich fraction from Larrea divaricata and its main flavonoid quercetin‐3‐methyl ether induce apoptosis in lymphoma cells through nitrosative stress
Liu et al. Ginsenoside C‐Mx isolated from notoginseng stem‐leaf ginsenosides attenuates ultraviolet B‐mediated photoaging in human dermal fibroblasts
Ji et al. Amino acid sequence identification of goji berry cyclic peptides and anticervical carcinoma activity detection
Karimian et al. The chemopreventive effect of Tanacetum polycephalum against LA7-induced breast cancer in rats and the apoptotic effect of a cytotoxic sesquiterpene lactone in MCF7 cells: a bioassay-guided approach
Shin et al. Isocudraxanthone K Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via Hypoxia Inducible Factor‐1α
Kumar et al. Antiproliferative activity and nitric oxide production of a methanolic extract of Fraxinus micrantha on Michigan Cancer Foundation-7 mammalian breast carcinoma cell line
ATE303814T1 (de) Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos
Hsieh et al. Autophagy inhibition enhances apoptosis induced by dioscin in huh7 cells
Lee et al. A study of the anti-cancer effects of the hexane fraction of the methanol extract of Forsythiae fructus
Abdel‐Bakky et al. Targeting the PI3K/pAKT/mTOR/NF‐κB/FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties